Literature DB >> 35261667

Changes of Gastric Secretion after Bolus and Slow Intravenous Administration of Bombesin and Neurotensin.

Konstantinos Tsalis1, Orestis Ioannidis1, Chrysovalantis Mariorakis1, Panagiotis Christidis1, Lydia Loutzidou1, Ioannis Mantzoros1, Efstathios Kotidis1, Manousos George Pramateftakis1, Nikolaos Ouzounidis1, Stamatios Aggelopoulos1.   

Abstract

Objectives: The aim of the present study was to evaluate the changes caused by intravenous administration of regulatory peptides, bombesin (BBS) and neurotensin (NT), on gastric secretion, serum gastrin, and plasma levels of bombesin-1ike immunoreactivity (BLI) and neurotensin. Materials and methods: Fourteen dogs underwent an upper gastrointestinal tract operation and a Pavlov pouch for the concentration of gastric fluids was formed. The experimental animals were divided into two groups. Peptides were given one month after the second operation and after fasting for 12 hours. In group A, the effects of BBS were studied after a rapid 1 ìg/kg body weight dose and a slow 30´ 0.5 ìg/kg body weight dose administration intravenously. Correspondingly to group B the effects of NT were studied in the same way.
Results: The rapid intravenous infusion of BBS caused a very significant increase in gastrin levels, BLI in plasma, volume and HCl of the gastric fluids. The same results, plus a significant decrease in gastric pH, were observed following slow intravenous infusion of BBS. Concerning the NT, rapid administration caused a significant decrease in the volume of gastric fluids. Slow NT administration of caused a significant reduction in gastric fluid volume and in HCl. On the contrary, pH was significantly increased.
Conclusion: Bombesin increases plasma gastrin levels and HCl secretion. Neurotensin administration causes a decrease in HCl secretion without affecting gastrin levels in plasma.

Entities:  

Year:  2021        PMID: 35261667      PMCID: PMC8897808          DOI: 10.26574/maedica.2021.16.4.642

Source DB:  PubMed          Journal:  Maedica (Bucur)        ISSN: 1841-9038


  83 in total

1.  Bombesin-like immunoreactivity in the lung.

Authors:  J Wharton; J M Polak; S R Bloom; M A Ghatei; E Solcia; M R Brown; A G Pearse
Journal:  Nature       Date:  1978-06-29       Impact factor: 49.962

2.  The actions of bombesin on gastric secretion of the dog and the rat.

Authors:  G Bertaccini; V Erspamer; M Impicciatore
Journal:  Br J Pharmacol       Date:  1973-11       Impact factor: 8.739

Review 3.  Distribution of neurotensin and its receptor in the central nervous system.

Authors:  G R Uhl
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

4.  Inhibitory role of the distal small intestine on the gastric secretory response to meals in man.

Authors:  J E Clain; V L Go; J R Malagelada
Journal:  Gastroenterology       Date:  1978-04       Impact factor: 22.682

5.  Effect of bombesin on extragastric gastrin in man.

Authors:  N Basso; E Lezoche; A Materia; S Giri; V Speranza
Journal:  Am J Dig Dis       Date:  1975-10

Review 6.  Contribution of neurotensin in the immune and neuroendocrine modulation of normal and abnormal enteric function.

Authors:  Konstantinos Kalafatakis; Konstantinos Triantafyllou
Journal:  Regul Pept       Date:  2011-05-04

7.  Fat inhibition of gastric acid secretion in man and plasma concentrations of neurotensin-like immunoreactivity.

Authors:  B Kihl; A Rökaeus; S Rosell; L Olbe
Journal:  Scand J Gastroenterol       Date:  1981       Impact factor: 2.423

8.  Effects of sham feeding, bethanechol, and bombesin on somatostatin release in dogs.

Authors:  J De Graef; M C Woussen-Colle
Journal:  Am J Physiol       Date:  1985-01

9.  Neurotensin in plasma: immunochemical and chromatographic character of acid/acetone-soluble material.

Authors:  R Carraway; R A Hammer; S E Leeman
Journal:  Endocrinology       Date:  1980-08       Impact factor: 4.736

10.  Positron Emission Tomography Imaging of the Gastrin-Releasing Peptide Receptor with a Novel Bombesin Analogue.

Authors:  Joseph Lau; Etienne Rousseau; Zhengxing Zhang; Carlos F Uribe; Hsiou-Ting Kuo; Jutta Zeisler; Chengcheng Zhang; Daniel Kwon; Kuo-Shyan Lin; François Bénard
Journal:  ACS Omega       Date:  2019-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.